AMETEK Posts Record Q2, Raises 2026 EPS Guidance to $8.20-$8.30
AME sits 38% above its 52-week low of $179.235.
Summary
AMETEK delivered record Q2 results with sales of $2.04B, up 15% YoY, and adjusted EPS of $2.09, a 17% increase. Orders surged 28%, driven by strength in semiconductor, aerospace, medtech, defense, and automation markets. Management raised full-year 2026 adjusted EPS guidance to $8.20-$8.30 from $7.94-$8.14, reflecting strong underlying performance and a robust outlook. This follows the $5B Indicor Instrumentation acquisition announced in May and the $7.5B debt financing secured in June, underscoring aggressive capital deployment. The guidance raise and broad-based order momentum signal sustained growth, with Q3 adjusted EPS expected at $2.08-$2.10. The earnings call later today will provide further color on segment trends and acquisition integration.
At the time of this announcement, AME was trading at $247.59 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $55.9B. The 52-week trading range was $179.24 to $244.97. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.